US8865698 — Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds
Method of Use · Assigned to Array Biopharma Inc · Expires 2029-10-21 · 3y remaining
What this patent protects
This patent protects methods for treating various conditions in mammals using a therapeutically effective amount of a compound of Formula I.
USPTO Abstract
Provided herein are methods for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal, which comprises administering to said mammal in need thereof a therapeutically effective amount of a compound of Formula I: in which R 1 , R 2 , R 3 , R 4 , X, Y and n have the meanings given in the specification.
Drugs covered by this patent
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-2469 |
— | larotrectinib-sulfate |
U-2469 |
— | larotrectinib-sulfate |
U-2469 |
— | larotrectinib-sulfate |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.